Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes

NCT00994292 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1276

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: YM150
DRUG: Placebo

Sponsor

Astellas Pharma Europe B.V.